Is Merit Medical Systems, Inc. (MMSI) a good stock to buy?

Olyth's institutional analysis of MMSI reveals an Altman Z-Score of 3.79 and a Piotroski F-Score of 7/9. These metrics, combined with its 5-year revenue trend ($1.52B most recent), help investors decide if MMSI fits their risk profile.

What is the current P/E ratio for MMSI?

As of the latest trading session, Merit Medical Systems, Inc. (MMSI) has a trailing P/E ratio of 31.13.

Who is the CEO of Merit Medical Systems, Inc.?

The current Chief Executive Officer of Merit Medical Systems, Inc. is Neil W. Peterson.

What was MMSI's revenue for the last 5 years?

According to its latest income statements, Merit Medical Systems, Inc. reported annual revenues of $1.52B (2025), $1.36B (2024), $1.26B (2023), $1.15B (2022), $1.07B (2021) respectively.

Does MMSI pay a dividend?

Merit Medical Systems, Inc. does not currently pay a dividend to its shareholders.

How much debt and cash flow does MMSI have?

In its latest reporting period, Merit Medical Systems, Inc. generated $0.22B in Free Cash Flow against a total debt load of $0.90B.

What is the Price-to-Book (P/B) ratio of Merit Medical Systems, Inc.?

The Price-to-Book (P/B) ratio for Merit Medical Systems, Inc. (MMSI) is currently 2.52.

What is the Price-to-Sales (P/S) ratio of MMSI?

Based on trailing twelve-month data, Merit Medical Systems, Inc. (MMSI) trades at a Price-to-Sales (P/S) ratio of 2.64.

What is Merit Medical Systems, Inc.'s Return on Equity (ROE)?

Merit Medical Systems, Inc. (MMSI) has a Return on Equity (ROE) of 8.52%, representing its profitability relative to shareholder equity.

MMSI

Merit Medical Systems, Inc. · Healthcare

67.40

0.60%(-0.41)

69.12

2.55%(+1.72)

After Hours

Last Updated: — ET

52W L: $66.3452W H: $100.19

$67.40

CHG-5.22 (-7.19%)

H$73.00

L$66.00

VOL14M

MMSI (1h)

Company Profile

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Employees

7,400

IPO Date

1990-05-14

Beta

0.65

Websitewww.merit.com↗

MMSI

Merit Medical (MMSI) is a Top-Ranked Value Stock: Should You Buy?

SG Americas Securities LLC Takes Position in Merit Medical Systems, Inc. $MMSI

Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Rating of “Moderate Buy” by Analysts

Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026

MMSI Expands Oncology Offering With View Point Medical Acquisition

Why Is Merit Medical (MMSI) Down 14% Since Last Earnings Report?